Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial

PURPOSE: Physicians sometimes make management recommendations on the basis of early results from randomized controlled trials (RCTs) relating to reduced prostate-specific antigen (PSA) failure, yet whether this early end point is associated with all-cause mortality (ACM), particularly in men with co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Giacalone, Nicholas J., Wu, Jing, Chen, Ming-Hui, Renshaw, Andrew, Loffredo, Marian, Kantoff, Philip W., D’Amico, Anthony V.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791839/
https://ncbi.nlm.nih.gov/pubmed/27601545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.68.4530
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados